Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009)

BMC Infectious Diseases

Adelaide Almeida¹  António Rodrigues²  Teresa Raposo²  Inês Linhares¹ 

[1] Department of Biology and CESAM, University of Aveiro, 3810-193, Aveiro, Portugal;Clinical Analysis Laboratory Avelab, Rua Cerâmica do Vouga, 3800-011, Aveiro, Portugal

关键词: Multidrug resistance;    Antimicrobial resistance;    Antibiotics;    Uropathogens;    Community-acquired urinary tract infection;   

Others  :  1158579
DOI  :  10.1186/1471-2334-13-19

 received in 2012-05-27, accepted in 2013-01-15,  发布年份 2013

【 摘 要 】

Background

Urinary tract infection (UTI) is one of the most common infectious diseases at the community level. In order to assess the adequacy of the empirical therapy, the prevalence and the resistance pattern of the main bacteria responsible for UTI in the community (in Aveiro, Portugal) was evaluated throughout a ten-year period.

Methods

In this retrospective study, all urine samples from patients of the District of Aveiro, in ambulatory regime, collected at the Clinical Analysis Laboratory Avelab during the period 2000–2009 were analysed. Samples with more than 10⁵ CFU/mL bacteria were considered positive and, for these samples, the bacteria were identified and the profile of antibiotic susceptibility was characterized.

Results

From the 155597 samples analysed, 18797 (12.1%) were positive for bacterial infection. UTI was more frequent in women (78.5%) and its incidence varied with age, affecting more the elderly patients (38.6%). Although E. coli was, as usual, the most common pathogen implicated in UTI, it were observed differences related to the other bacteria more implicated in UTI relatively to previous studies. The bacteria implicated in the UTI varied with the sex of the patient, being P. aeruginosa a more important cause of infection in men than in women. The incidence of the main bacteria changed over the study period (P. aeruginosa, Klebsiella spp and Providencia spp increased and Enterobacter spp decreased). Although E. coli was responsible for more than an half of UTI, its resistance to antibiotics was low when compared with other pathogens implicated in UTI, showing also the lowest percentage of multidrug resistant (MDR) isolates (17%). Bacteria isolated from females were less resistant than those isolated from males and this difference increased with the patient age.

Conclusions

The differences in sex and age must be taken into account at the moment of empirical prescription of antimicrobials. From the recommended antimicrobials by the European Association of Urology guidelines, the first line drugs (pivmecillinam and nitrofurantoin) and the alternative antibiotic amoxicillin-clavulanic acid (AMX-CLA) are appropriate to treat community-acquired UTI, but the fluoroquinolones should not be suitable to treat male infections and the trimethoprim-sulfamethoxazole (SXT) shall not be used in the treatment of UTI at this level.

【 授权许可】

   
2013 Linhares et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Arjunan M, Al-Salamah AA, Amuthan M: Prevalence and antibiotics susceptibility of uropathogens in patients from a rural environment. Tamilnadu. Am J Infect Dis 2010, 6:29-33.
• [2]Rahman F, Chowdhury S, Rahman MM, Ahmed D, Hossain A: Antimicrobial resistance pattern of gram-negative bacteria causing urinary tract infection. S J Phar Sci 2009, 2:44-55.
• [3]Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, Betltjewska K, Hryniewicz W: Antibiotic susceptibility of bacterial strains isolated from urinary tract. J Antimicrob Chemother 2001, 47:773-780.
• [4]Narciso A, Fonseca F, Cerqueira SA, Duarte A: Susceptibilidade aos antibióticos de bactérias responsáveis por cistites não complicadas: estudo comparativo dos isolados de 2008 e 2010. Acta Urol 2011, 1:16-21.
• [5]Sheerin NS: Urinary tract infection. Medicine 2011, 39:384-389.
• [6]Su C: Female lower urinary tract infection. JTUA 2008, 19:12-20.
• [7]Moura A, Nicolau A, Hooton T, Azeredo J: Antibiotherapy and pathogenesis of uncomplicated UTI: difficult relationships. J Appl Microbiol 2009, 106:1779-1791.
• [8]Akram M, Shahid M, Khan AU: Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007, 6:4. BioMed Central Full Text
• [9]Pires MCS, Frota KS, Junior POM, Correia AF, Cortez-Escalantes JJ, Silveira CA: Prevalence and bacterial susceptibility of community acquired urinary tract infection in University Hospital of Brasília, 2001 to 2005. Rev Soc Bras Med Trop 2007, 40:643-647.
• [10]Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N: Urinary tract infections in Brescia, Italy: Etiology of uropathogens and antimicrobial resitance of common uropathogens. Med Sci Monit 2007, 6:136-144.
• [11]Correia C, Costa E, Peres A, Alves M, Pombo G, Estevinho L: Etiologia das Infecções do Tracto Urinário e sua Susceptibilidade aos Antimicrobianos. Acta Médica Portuguesa 2007, 543-549.
• [12]Martins F, Vitorino J, Abreu A: Avaliação do Perfil de Susceptibilidade aos Antimicrobianos de Microorganismos Isolados em Urinas na Região do Vale so Sousa e Tâmega. Acta Med Port 2010, 23:641-646.
• [13]Mendo A, Antunes J, Costa M, Pereira PM, Monteiro C, Gomes CF, Gomes JF: Frequência de Infecções urinárias em Ambulatório - dados de um laboratório de Lisboa. Parte I. Revista Lusófona de Ciências e Tecnologia da Saúde 2008, 5:216-223.
• [14]Nimri L: Community-acquired urinary tract infections in a rural area in Jordan: predominant uropathogens, and their antimicrobial resistance. WebmedCentral MICROBIOLOGY 2010, 1:1-10.
• [15]Neto JAD, Martins ACP, Silva LDM, Tiraboshi RB, Domingos ALA, Cologna AJ, Paschoalia EL, Junior ST: Community acquired urinary tract infection etiology and bacterial susceptibility. Acta Cir Bras 2003, 18:33-36.
• [16]Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB: Community-onset urinary tract infections: a population-based assessment. Infection 2007, 35:150-153.
• [17]Costa M, Pereira PM, Bolotinha C, Ferreira A, Cardoso R, Monteiro C, Gomes CF, Gomes JF: Frequência e Susceptibilidade Bacteriana em Infecções Urinárias –dados de um laboratório de Lisboa. Parte II. Rev Lusófona de Ciências e Tecnologias da Saúde 2009, 6:87-103.
• [18]Wiles TJ, Kulesus RR, Mulvey MA: Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 2008, 85:11-19.
• [19]Stamm WE: host-pathogen interactions in community-acquired urinary tract infections. Trans Am Clin Climatol Assoc 2006, 117:75.
• [20]Savas L, Guvel S, Savas N, Duran N: Nosocomial urinary tract infections: micro-organisms, antibiotic sensitivities and risk factors. West Indian Med J 2006, 55:188-193.
• [21]Abubakar EM: Antimicrobial susceptibility pattern of pathogenic bacteria causing urinary tract infections at the Specialist Hospital, Yola, Adamawa state. Nigeria. J Clin Med Res 2009, 1:1-8.
• [22]Marques N, Araújo F, Ducla-Soares JL: Infecções e Antibioterapia num serviço de medicina. Medicina Interna 2005, 12:203.
• [23]Wagenlehner F: Antibiotics and resistance of uropathogens. EAU Updat Ser 2004, 2:125-135.
• [24]Wagenlehner FM, Hoyme U, Kaase M, Funfstuck R, Naber KG, Schmiemann G: Uncomplicated urinary tract infections. Dtsch Arztebl Int 2011, 108:415-423.
• [25]Grabe M, Bjerklund-Johansen TE, Botto H, Wullt B, Cek M, Naber KG, Pickard RS, Tenke P, Wagenlehner F: Guidelines on Urological Infections - 2011. European Association of Urology 2011, 112.
• [26]Alós JI: Epidemiologia y etiologia de la infección urinaria comunitaria. Sensibilidad antimicrobiana de los principales patógenos y significado clínico de la resistencia. Enferm Infecc Microbiol Clin 2005, 23:3-8.
• [27]Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A: The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009, 34:407-413.
• [28]den Heijer CD, Donker GA, Maes J, Stobberingh EE: Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother 2010, 65:2128-2133.
• [29]NCCLS: Abbreviated Identification of Bacteria and Yeast: Approved Guideline. In NCCLS document M35-A. Wayne, Pennsylvania; 2002.
• [30]CLSI: Clinical and Laboratory Standard Institute (CLSI), Performance standards for antimicrobial susceptibility testing. Wayne, PA, USA; 2010.
• [31]Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JS, Kahlmeter G, Olsson-Liljequist B, et al.: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Eur Soc Clin Microbiol Infect Dis 2011, 18:268-281.
• [32]Kuroda M, Yamashita A, Hirakawa H, Kumano M, Morikawa K, Higashide M, Maruyama A, Inose Y, Matoba K, Toh H, et al.: Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection. Proc Natl Acad Sci U S A 2005, 102:13272-13277.
• [33]Hooton T: Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother 2000, 46:1-7.
• [34]Kisich KO, Carspecken CW, Fieve S, Boguniewicz M, Leung DY: Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol 2008, 122:62-68.
• [35]Tortora GJ, Funke BR, Case CL: Microbial Diseases of the skin and eyes. In Microbiology an Introduction. P. Education edition. San Francisco, CA: Pearson Benjamin Cummings; 2010:584-591.
• [36]EARSS: European Antimicrobial Resistance Surveillance System. Netherlands: European Centre for Disease Prevention and Control; 2008.
• [37]Kanafani Z, Vance F: Staphylococcus aureus infections: New challenges from an Old pathogen. Enferm Infecc Microbiol Clin 2006, 24:182-193.
• [38]Kluytmans-Vandenbergh M, Kluytmans J: Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 2006, 12:9-15.
• [39]Tang YW, Stratton CW: Staphylococcus aureus: an old pathogen with new weapons. Clin Lab Med 2010, 30:179-208.
• [40]Thompson S, Yacomeni S, Townsend R: Antibiotics for uncomplicated urinary tract infection in women. Prescriber 2010, 21:15-28.
• [41]Raz R, Colodner R, Kunin CM: Who are you—Staphylococcus. Clin Infect Dis 2005, 40:896-898.
• [42]Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, Churchill BM, Haake DA: Uropathogens and host characteristics. J Clin Microbiol 2008, 46:3980-3986.
• [43]Ronald A: The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002, 113:14-19.
• [44]Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, Stobberingh EE: Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 2010, 76:336-340.
• [45]Schechner V, Nobre V, Kaye KS, Leshno M, Giladi M, Rohner P, Harbarth S, Anderson DJ, Karchmer AW, Schwaber MJ, Carmeli Y: Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis 2009, 48:580-586.
• [46]Tekiner : Nosocomial providencia stuartii meningitis: a case report. J Neurol Res 2011, 1:37-39.
• [47]Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A: Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 2009, 13:140-144.
• [48]Matthews SJ, Lancaster JW: Urinary tract infections in the elderly population. Am J Geriatr Pharmacother 2011, 9:286-309.
• [49]Al-Tawfiq JA, Antony A, Abed MS: Antimicrobial resistance rates of Enterobacter spp a seven-year surveillance study. Med Princ Pract 2009, 18:100-104.
• [50]Uzunovic-Kamberovic S: Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina. J Antimicrob Chemother 2006, 58:344-348.